Gaush Meditech Ltd
HKSE: 2407.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Xinwei Liu
- Employees
- 884
- Headquarters
- Beijing, China
- IPO year
- 2022
- Market cap
- HK$755.7M
- Website
- https://www.gaush.com
Loading 2407…
Loading profile data…Frequently asked questions about 2407
What does Gaush Meditech Ltd (2407.HK) do?
Gaush Meditech Ltd., together with its subsidiaries, researches and develops, produces, and sells ophthalmic medical devices in the People's Republic of China and internationally. The company operates through Proprietary Products, Distribution, Technical, and Others segments. Its ophthalmic medical devices are used for diagnosis, treatment, or s...
Where does 2407.HK trade?
Gaush Meditech Ltd (2407.HK) trades on the Hong Kong Stock Exchange.
What sector is 2407.HK in?
Gaush Meditech Ltd (2407.HK) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Gaush Meditech Ltd?
Xinwei Liu is the chief executive officer of Gaush Meditech Ltd (2407.HK).
Where is Gaush Meditech Ltd headquartered?
Gaush Meditech Ltd is headquartered in China.
Does 2407.HK pay a dividend?
Yes — Gaush Meditech Ltd (2407.HK) paid a trailing twelve-month dividend of HKD 0.30 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 2407.HK go public?
Gaush Meditech Ltd (2407.HK) completed its initial public offering in 2022.